CONSIDERATIONS IN THE DEVELOPMENT AND VALIDATION OF GENOMIC TESTS FOR CANCER RECURRENCE AND TREATMENT BENEFIT
Main Authors: | Kerr, D, O'Connell, M, Lavery, I, Gray, R, Yothers, G, Quirke, P, Lopatin, M, Clark-Langone, K, Lee, M, Wolmark, N |
---|---|
Format: | Conference item |
Published: |
2010
|
Similar Items
-
A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study
by: Kerr, D, et al.
Published: (2009) -
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
by: Gray, R, et al.
Published: (2011) -
Psychological Benefits of Physical Activity in Children with Mental Health Disorders
by: Janelle K. O’Connell, et al.
Published: (2020-06-01) -
Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
by: Sjoquist, K, et al.
Published: (2013) -
Enhancing Horticultural Crops through Genome Editing: Applications, Benefits, and Considerations
by: Melvin A. Daniel, et al.
Published: (2023-08-01)